Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Researchers see promise in use of iPS cells for macular degeneration
An experimental therapy based on the use of skin cell-derived induced pluripotent stem cells has the potential to treat macular degeneration in people, according to a study published in Molecular Medicine. "With eye diseases, I think we're getting close to a scenario where a patient's own skin cells are used to replace retina cells destroyed by disease or degeneration," said Dr. Stephen Tsang of Columbia University Medical Center.
United Press International (10/7)
Or we can send an email on your behalf